Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central dazzle. A thalamic syndrome?

J L Cummings, J W Gittinger

    Archives of Neurology
    |June 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Central dazzle, a painless light intolerance, may be a variant of thalamic syndrome. This condition, following posterior cerebral artery occlusion, responded to specific medical therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders.

    International psychogeriatrics·2025
    Same author

    Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy Adults.

    The journal of prevention of Alzheimer's disease·2022
    Same author

    Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD).

    The journal of prevention of Alzheimer's disease·2020
    Same author

    TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology.

    The journal of prevention of Alzheimer's disease·2020
    Same author

    The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.

    The journal of prevention of Alzheimer's disease·2020
    Same author

    Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease.

    International journal of clinical practice·2015
    Same journal

    Incorrect Table Entries and Word.

    Archives of neurology·2016
    Same journal

    IDEAL for CCSVI Research-Reply.

    Archives of neurology·2013
    Same journal

    Atlas of Inherited Metabolic Diseases, 3rd ed.

    Archives of neurology·2013
    Same journal

    Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

    Archives of neurology·2013
    Same journal

    This month in archives of neurology.

    Archives of neurology·2013
    Same journal

    About this journal.

    Archives of neurology·2013
    See all related articles

    Area of Science:

    • Neuroscience
    • Ophthalmology
    • Neurology

    Background:

    • Posterior cerebral artery occlusion can lead to various neurological deficits.
    • Thalamic lesions are associated with sensory disturbances, including pain syndromes.

    Observation:

    • A patient presented with delayed-onset, painless photophobia (dazzle) three months post-right posterior cerebral artery occlusion.
    • Computerized tomography revealed infarction in the right occipital lobe and right thalamus.

    Findings:

    • The patient's symptoms of central dazzle significantly improved with amitriptyline hydrochloride and perphenazine treatment.
    • The clinical presentation, including delayed onset and thalamic involvement, mirrors aspects of the thalamic pain syndrome.

    Implications:

    Related Experiment Videos

    • Central dazzle may represent a distinct variant of the thalamic syndrome.
    • This suggests a potential therapeutic pathway for similar light sensitivity disorders originating from thalamic damage.